|
Status |
Public on Jun 01, 2017 |
Title |
SFC848-03-02 |
Sample type |
genomic |
|
|
Source name |
induced pluripotent stem cell line derived from dermal fibroblasts, control donor 848, clone 2
|
Organism |
Homo sapiens |
Characteristics |
gender: male donor: control donor culture conditions: mTeSR-1 + matrigel cell type: induced pluripotent stem cells derived from dermal fibroblasts
|
Treatment protocol |
untreated cell samples; fibroblasts grown in ADMEM + 10% FCS; iPSc lines all grown in mTeSR-1 medium + ES-qualified matrigel prior to harvest
|
Extracted molecule |
genomic DNA |
Extraction protocol |
genomic DNA was extracted using QIAGEN DNeasy blood and tissue kit
|
Label |
Biotin (C, G), Dinitrophenyl (A, T)
|
Label protocol |
Standard Illumina labelling protocol
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol for BeadChip Arrays
|
Description |
single replicate
|
Data processing |
The scanned data files were processed by GenomeStudio Genotyping module v1.9, using the cluster file and manifest HumanCytoSNP-12v2-1_H provided by Illumina for GPL13829, and humanomniexpress_24v1-1_a for GPL22678. Raw data was also uploaded to KaryoStudio (Illumina) for generation of karyotype reports (see publication).
|
|
|
Submission date |
May 31, 2017 |
Last update date |
Jun 01, 2017 |
Contact name |
Sally A Cowley |
E-mail(s) |
sally.cowley@path.ox.ac.uk
|
Phone |
+44 (0) 1865 275600
|
Organization name |
University of Oxford
|
Department |
Sir William Dunn School of Pathology
|
Lab |
James Martin Stem Cell Facility
|
Street address |
South Parks Road
|
City |
Oxford |
ZIP/Postal code |
OX1 3RE |
Country |
United Kingdom |
|
|
Platform ID |
GPL22678 |
Series (2) |
GSE99471 |
SNP genotype data from induced Pluripotent Stem cells from Parkinson's Disease patients harboring mutations in the GBA1 gene, and from healthy control donors |
GSE99473 |
SNP Genotype and Gene Expression data from induced Pluripotent Stem cells from Parkinson's Disease patients harboring mutations in the GBA1 gene, and from healthy control donors |
|